(Q82901856)
Statements
Intravenous and intradermal TriMix-dendritic cell therapy results in a broad T-cell response and durable tumor response in a chemorefractory stage IV-M1c melanoma patient (English)
Daphné Benteyn
Sofie Wilgenhof
Jurgen Corthals
Carlo Heirman
Bart Neyns
10 December 2011